Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection
- Michael Weekes,
- Nick K Jones,
- Lucy Rivett,
- Chris Workman,
- Mark Ferris,
- Ashley Shaw,
- Cambridge Covid-19 Collaboration,
- Paul J Lehner,
- Rob Howes,
- Giles Wright,
- Nicholas J Matheson,
- Michael P Weekes
Nick K Jones
Clinical Microbiology & Public Health Laboratory, Public Health England
Lucy Rivett
Clinical Microbiology & Public Health Laboratory, Public Health England
Chris Workman
Cambridge University Hospitals Occupational Health and Wellbeing
Mark Ferris
Cambridge University Hospitals Occupational Health and Wellbeing
Ashley Shaw
Cambridge University Hospitals
Cambridge Covid-19 Collaboration
Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge
Paul J Lehner
Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge
Rob Howes
Cambridge COVID-19 Testing Centre
Giles Wright
Cambridge University Hospitals Occupational Health and Wellbeing
Nicholas J Matheson
NHS Blood and Transplant, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge
Michael P Weekes
Cambridge Institute for Medical Research, University of Cambridge
